Castle Biosciences Honored with Top Workplaces Awards
Castle Biosciences (Nasdaq: CSTL) has been recognized with several prestigious awards through the 2024 Top Workplaces program. The company earned its third consecutive Arizona Top Workplaces award from AZ Central, a second consecutive national Healthcare Industry Top Workplace award, and five Top Workplaces Culture Excellence Awards for Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership, and Purpose & Values. These accolades are based on anonymous employee feedback collected via a third-party survey by Energage, emphasizing Castle's commitment to a positive workplace culture.
CEO Derek Maetzold expressed pride in the repeated recognition, attributing it to the company's dedication to fostering an exceptional, people-first environment that promotes employee growth and patient care. The Top Workplaces program, now in its 17th year, evaluates companies based on 15 culture drivers, including alignment, execution, and connection.
- None.
- None.
Castle earns recognition as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards
“We are incredibly honored to have been named a Top Workplace in
Now in its 17th year, the Top Workplaces program surveys and celebrates people-first organizations nationally and across 60 regional markets. Top Workplace designations are garnered solely through anonymous employee feedback gathered through a third-party survey administered by Energage. The confidential survey uniquely measures the employee experience and its component themes, including employees feeling “respected & supported,” “enabled to grow” and “empowered to execute,” among others. Additionally, it measures 15 culture drivers that are indicative of successful organizations, such as alignment, execution and connection.
Earlier this year, Castle earned a national Top Workplaces award (also for the third consecutive year) and also received five Top Workplaces Culture Excellence Awards (multiple years running) for continued excellence in the following areas of its company culture:
- Innovation (2022, 2023, 2024), for creating a culture where new ideas are encouraged, which helps employees reach their full potential and benefits performance.
- Work-Life Flexibility (2023, 2024), for building a culture that enables employees to meet the demands of their personal lives while maintaining high performance.
- Compensation & Benefits (2022, 2023, 2024), for providing packages employees believe are fair for the work being done and compared to others in the industry.
- Leadership (2022, 2023, 2024), for organizational leaders who inspire confidence in employees and the company direction, listening to what matters most to employees and using that insight in decision making.
- Purpose & Values (2022, 2023, 2024), for successfully communicating the company mission and integrating those aspirations into the culture.
“Earning a Top Workplaces award is a badge of honor for companies, especially because it comes authentically from their employees,” said Eric Rubino, Energage chief executive officer. “In today's market, leaders must ensure they’re allowing employees to have a voice and be heard; that's paramount. Top Workplaces do this, and it pays dividends.”
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
About Energage
Making the world a better place to work together.™
Energage is a purpose-driven company that helps organizations turn employee feedback into useful business intelligence and credible employer recognition through Top Workplaces. Built on 18 years of culture research and the results from 27 million employees surveyed across more than 70,000 organizations, Energage delivers the most accurate competitive benchmark available. With access to a unique combination of patented analytic tools and expert guidance, Energage customers lead the competition with an engaged workforce and an opportunity to gain recognition for their people-first approach to culture. For more information or to nominate your organization, visit energage.com or topworkplaces.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240711288149/en/
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
FAQ
What awards has Castle Biosciences received in 2024?
What is the significance of the Top Workplaces awards Castle Biosciences won?
How many times has Castle Biosciences won the Arizona Top Workplaces award?
How does Castle Biosciences collect feedback for the Top Workplaces awards?
Who is the CEO of Castle Biosciences?